Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Long-Term Survival Following Nivolumab Treatment in Pulmonary Tumour Thrombotic Microangiopathy Associated With Cancer of Unknown Primary: A Case Report. (PubMed, Respirol Case Rep) - Oct 3, 2026 - "Despite transient severe deterioration, the patient's respiratory function improved markedly, and he has remained progression-free for more than 3 years. This case highlights the importance of early clinical recognition of PTTM and prompt initiation of appropriate systemic therapy, even before definitive identification of the primary tumour when clinically warranted." 
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • Hypertension • Lung Cancer • Oncology • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases • NKX2-1
http://www.ncbi.nlm.nih.gov/pubmed/42824682
 
Hiroyuki Suzuki; Jun Osugi; Kosuke Fujishima; Mitsunori Higuchi; Satoshi Noma
 
Oct 3, 2026
 
Prev Next